Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of 618.9 million as of January 8, 2026. Its market cap has increased by 552.84% in one year.

Market Cap

618.90M

Enterprise Value

563.40M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

260.00

Market Cap Chart

Since March 26, 2019, Enlivex Therapeutics's market cap has increased from 368.04M to 618.90M, an increase of 68.16%. That is a compound annual growth rate of 7.96%.

Market Cap History

Date	Market Cap	% Change
Jan 6, 2026	616.06M	15.77%
Dec 31, 2025	532.16M	467.89%
Dec 31, 2024	93.71M	-48.18%
Dec 29, 2023	180.84M	-29.06%
Dec 30, 2022	254.92M	-28.46%
Dec 31, 2021	356.33M	-8.65%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Mar 26, 2019	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	113.17B
Danel (Adir Yeoshua)	2.93B
Kamada	1.31B
BrainsWay	1.25B
Bait Bakfar	1.01B
SofWave Medical	1.01B
Ilex Medical	752.96M
Novolog (Pharm-Up 1966)	643.70M

Market Cap Rankings